Skip to main content
Signal8

Ray Sumita

SEC insider (Form 3/4/5 filer). CIK 0001579629. Chief Legal Compliance Officer at Cue Biopharma, Inc. (CUE) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in SOMERVILLE, MA.

Companies Ray Sumita has filed insider reports for

  • Cue Biopharma, Inc. (CUE): Officer, Chief Legal Compliance Officer
  • Biomea Fusion, Inc. (BMEA): Director
Ray Sumita profile photo

Ray Sumita

CIK: 0001579629

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Cue Biopharma, Inc. logo
CUE

Cue Biopharma, Inc.

Officer
Biomea Fusion, Inc. logo
BMEA

Biomea Fusion, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Oct 12, 2026
    Sale
    Direct
    1.8K shares at avg. $28.05$52K
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Aug 13, 2026
    Exercise
    Direct
    18.2K shares-
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Aug 13, 2026
    Sale
    Direct
    2.4K shares at avg. $29.37$70K
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Aug 13, 2026
    Sale
    Direct
    6.4K shares at avg. $30.35$196K
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Aug 13, 2026
    Sale
    Direct
    4 shares at avg. $31.13$124.52
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Jul 9, 2026
    Award
    Direct
    54.6K shares-
  • Biomea Fusion, Inc. logo
    BMEA

    Biomea Fusion, Inc.

    Jun 10, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    196.3K shares-
  • Biomea Fusion, Inc. logo
    BMEA

    Biomea Fusion, Inc.

    Jun 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    92K shares-

1-8 of 8